Using E0771 tumor models, we confirmed the efficacy of the S-V9 mAb in significantly inhibiting E0771 tumor growth, reducing tumor weight and decreasing tumor ALDH1 activity, as consistently observed (Fig. 6A C). The gene discussed is ALDH1A1; the disease is neoplasm.